1-2 of 2
Veronica Bunn
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Role of stem cell transplant in CD30 + PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Clinical Trials & Observations
Kerry J. Savage, Steven M. Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trneny, Sam Yuen, Pier Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A. O’Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5550–5555.
https://doi.org/10.1182/bloodadvances.2020003971
Published: 2022
Includes: Supplemental data
Journal Articles

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

Clinical Trials & Observations
Steven M. Horwitz, Julia J. Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E. Akilov, Larisa Geskin, Jose A. Sanches, Pablo L. Ortiz-Romero, Michael Weichenthal, David C. Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, H. Miles Prince
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5098–5106.
https://doi.org/10.1182/bloodadvances.2021004710
Published: 2021
Includes: Supplemental data